Abbott Laboratories (NYSE:ABT) Insider Trading Activity – SVP Sold 21,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Abbott Laboratories (NYSE:ABT)

Randel William Woodgrift , SVP of Abbott Laboratories (NYSE:ABT) reportedly Sold 21,000 shares of the company’s stock at an average price of 80.54 for a total transaction amount of $1,691,340.00 SEC Form

Insider Trading History For Abbott Laboratories (NYSE:ABT)

  • On 2/1/2013 William A Osborn, Director, bought 10,000 with an average share price of $33.86 per share and the total transaction amounting to $338,600.00.
  • On 6/7/2013 Heather L Mason, SVP, sold 12,000 with an average share price of $37.01 per share and the total transaction amounting to $444,120.00.
  • On 10/30/2013 Jaime Contreras, SVP, sold 25,368 with an average share price of $36.85 per share and the total transaction amounting to $934,810.80.
  • On 11/7/2013 Stephen Fussell, EVP, sold 10,466 with an average share price of $37.59 per share and the total transaction amounting to $393,416.94.
  • On 12/6/2013 Jean-Yves Pavee, SVP, sold 5,855 with an average share price of $37.46 per share and the total transaction amounting to $219,328.30.
  • On 1/29/2014 Michael Warmuth, EVP, sold 11,430 with an average share price of $36.21 per share and the total transaction amounting to $413,880.30.
  • On 2/18/2014 John Landgraf, EVP, sold 1,583 with an average share price of $39.10 per share and the total transaction amounting to $61,895.30.

    • Analyst Ratings History For Abbott Laboratories (NYSE:ABT)

    • On 1/3/2018 Evercore ISI Initiated Coverage of rating Outperform to Outperform with a price target of $64.00
    • On 1/25/2018 Leerink Swann Reiterated Rating Market Perform with a price target of $60.00 to $68.00
    • On 1/25/2018 Guggenheim Reiterated Rating Buy with a price target of $72.00
    • On 6/27/2018 Sanford C. Bernstein Initiated Coverage of rating Outperform with a price target of $73.00
    • On 7/19/2018 Stifel Nicolaus Boost Price Target of rating Buy to Buy with a price target of $71.00 to $72.00
    • On 10/8/2018 JPMorgan Chase & Co. Boost Price Target of rating Overweight to Overweight with a price target of $77.00 to $81.00
    • On 11/27/2018 UBS Group Initiated Coverage of rating Buy with a price target of $83.00

    Dividend Information For Abbott Laboratories (NYSE:ABT)
    Abbott Laboratories (NYSE:ABT) pays an annual dividend of $1.28 with a yield of 1.57% and an average dividend growth of 0.00% (3 Year Average).

    Dividend History For Abbott Laboratories (NYSE:ABT)

  • On 12/14/2012 Abbott Laboratories announced a quarterly dividend of $0.14 0.86% with an ex dividend date of 1/11/2013 which will be payable on 2/15/2013.
  • On 2/15/2013 Abbott Laboratories announced a quarterly dividend of $0.14 1.61% with an ex dividend date of 4/11/2013 which will be payable on 5/15/2013.
  • On 6/14/2013 Abbott Laboratories announced a quarterly dividend of $0.14 1.52% with an ex dividend date of 7/11/2013 which will be payable on 8/15/2013.
  • On 9/12/2013 Abbott Laboratories announced a quarterly dividend of $0.14 1.61% with an ex dividend date of 10/10/2013 which will be payable on 11/15/2013.
  • On 10/16/2013 Abbott Laboratories announced a quarterly dividend of $0.22 2.37% with an ex dividend date of 1/13/2014 which will be payable on 2/15/2014.
  • On 2/21/2014 Abbott Laboratories announced a quarterly dividend of $0.22 2.26% with an ex dividend date of 4/11/2014 which will be payable on 5/15/2014.
  • On 6/13/2014 Abbott Laboratories announced a quarterly dividend of $0.22 2.21% with an ex dividend date of 7/11/2014 which will be payable on 8/15/2014.

    • Recent Trading Activity for Abbott Laboratories (NYSE:ABT)
    Shares of Abbott Laboratories closed the previous trading session at with 81.08 shares trading hands.